4//SEC Filing
Easom Eric 4
Accession 0000899243-23-013012
CIK 0001880438other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 8:01 PM ET
Size
10.8 KB
Accession
0000899243-23-013012
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-05-15$5.38/sh+10,000$53,770→ 1,015,766 total(indirect: See Footnote)
Holdings
- 4,907
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
- 97,058(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- [F2]Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
- [F3]Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 8:01 PM ET
- Size
- 10.8 KB